54 related articles for article (PubMed ID: 2888712)
41. Adverse effects in maintenance therapy.
Ban TA
Int Pharmacopsychiatry; 1978; 13(4):217-29. PubMed ID: 32148
[TBL] [Abstract][Full Text] [Related]
42. Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin.
Sandyk R
Int J Neurosci; 1990 Jun; 52(3-4):233-8. PubMed ID: 2269610
[TBL] [Abstract][Full Text] [Related]
43. [Pharmacology-biochemistry and physiopathology of tardive dyskinesia: review of the latest findings and controversies].
Gómez-Galera A
Arch Biol Med Exp; 1988 Jun; 21(1):65-9. PubMed ID: 2908731
[TBL] [Abstract][Full Text] [Related]
44. Medical treatment of mental illness.
Berger PA
Science; 1978 May; 200(4344):974-81. PubMed ID: 25487
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology of tardive dyskinesia.
Kane JM; Woerner M; Weinhold P; Kinon B; Lieberman J; Wegner J
Clin Neuropharmacol; 1983 Jun; 6(2):109-15. PubMed ID: 6342767
[No Abstract] [Full Text] [Related]
46. Current views on tardive dyskinesia.
Gerlach J
Pharmacopsychiatry; 1991 Mar; 24(2):47-8. PubMed ID: 1852791
[No Abstract] [Full Text] [Related]
47. Anticholinergic drugs in psychiatry.
Mallett P
Int Clin Psychopharmacol; 1989 Oct; 4(4):261-71. PubMed ID: 2691572
[TBL] [Abstract][Full Text] [Related]
48. Oxygen radicals and neuropsychiatric illness. Some speculations.
Lohr JB
Arch Gen Psychiatry; 1991 Dec; 48(12):1097-106. PubMed ID: 1845228
[TBL] [Abstract][Full Text] [Related]
49. [Tardive dyskinesia (author's transl)].
Reches A; Melamed E
Harefuah; 1977 May; 92(10):458-61. PubMed ID: 328348
[No Abstract] [Full Text] [Related]
50. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
Wolf ME; DeWolfe AS; Mosnaim AD
Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
[TBL] [Abstract][Full Text] [Related]
51. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
Kane JM
J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
[TBL] [Abstract][Full Text] [Related]
52. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia].
Kaiser W
Nervenarzt; 1989 Apr; 60(4):206-12. PubMed ID: 2566936
[No Abstract] [Full Text] [Related]
53. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
Barnes TR
Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
[TBL] [Abstract][Full Text] [Related]
54. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
Glazer WM
J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
